Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.641260
Abstract: Virulence arresting drugs (VAD) are an expanding class of antimicrobial treatment that act to “disarm” rather than kill bacteria. Despite an increasing number of VAD being registered for clinical use, uptake is hampered by the… read more here.
Keywords: catalyst targeted; antivirulence therapeutics; targeted antivirulence; microbial genomics ... See more keywords